Diversa Forms Product Development and Marketing Collaboration With Bayer Animal Health
Tuesday January 13, 6:30 am ET
Collaboration to Focus on Developing and Manufacturing Microbially-Produced Vaccines for Aquaculture
SAN DIEGO, Jan. 13 /PRNewswire-FirstCall/ -- Diversa Corporation (Nasdaq: DVSA - News) today announced that it has formed a collaboration with Bayer Animal Health to develop and market products to prevent infectious diseases in fish. Under the agreement, Diversa and Bayer will collaborate to complete the development and registration of an existing pipeline of microbially-produced vaccines for aquaculture previously developed by a Bayer venture. These novel proprietary products will be manufactured by Diversa and exclusively marketed and distributed by Bayer in designated markets within the Bayovac® product line.
"The agreement with Bayer is an excellent opportunity to leverage Diversa's protein development and manufacturing expertise and Bayer Animal Health's global marketing and distribution networks in the animal health industry," stated William H. Baum, Executive Vice President of Diversa Corporation. "Diversa's capabilities in protein discovery, development, and manufacturing are well-suited to address high-value animal health markets."
The collaboration will focus initially on developing and manufacturing microbially-produced vaccine products for aquaculture, the fastest growing component of the animal health market. Diversa and Bayer expect to explore new, additional animal health applications and product opportunities in the future.
About Diversa
Diversa Corporation is a leader in applying proprietary genomic technologies for the rapid discovery and optimization of novel products from genes and gene pathways. Diversa is directing its integrated portfolio of technologies to the discovery, evolution, and production of commercially valuable molecules with pharmaceutical applications, such as optimized monoclonal antibodies and orally active drugs, as well as enzymes and small molecules with agricultural, chemical, and industrial applications. In addition, Diversa has formed alliances and joint ventures with market leaders, such as BASF, The Dow Chemical Company, DuPont Bio-Based Materials, Givaudan Flavors Corporation, GlaxoSmithKline plc, Invitrogen Corporation, and affiliates of Syngenta AG. Additional information is available at Diversa's website: www.diversa.com . |
